RootPath

United States
Primghar, Iowa, United States, 02139

Company profile

RootPath company profile

RootPath is a Cambridge-based biotechnology company developing a powerful personalized T cell therapy platform that bridges precision medicine and cancer immunotherapy. Their next generation technologies allow us to precisely monitor, modulate and steer the immune system for a revolution in the diagnosis and treatment of cancer.

Business identity

Contact email
[email protected]
Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Revenue range
$0+
Founded
2017-01-01, Year

Headquarters

Postal code
02139
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding rounds
4
Total equity funding
$69.4M
Last funding
Series Unknown / $1.4M / 2025-04-24
Last equity funding
Series Unknown / $1.4M
Investors
12
Lead investors
6
Founders
5
Articles
10

Founders and investors

Founders

Cheryl CuiEly PorterLe CongXi ChenYinquing Li

Lead investors

BioVentureCDH InvestmentsHSGMatrix Partners ChinaOriza Seed Capital (Oriza Yuandian)Sky9 Capital

Investors

Baidu VenturesCDH InvestmentsHSGMatrix Partners ChinaSky9 Capital